Fully biologically active when compared to standard. The biologically active as determined by its ability to inhibit TNF-beta -mediated cytotoxicity using murine L929 cells.
Purity Function >95% (SDS-PAGE&HPLC) Endotoxin level <0.1 EU/μg Function Receptor for BTLA. Receptor for TNFSF14/LIGHT and homotrimeric TNFSF1/lymphotoxin-alpha. Involved in lymphocyte activation. Plays an important role in HSV pathogenesis because it enhanced the entry of several wild-type HSV strains of both serotypes into CHO cells, and mediated HSV entry into activated human T-cells.
Fully biologically active when compared to standard. The biologically active as determined by its ability to inhibit TNF-beta -mediated cytotoxicity using murine L929 cells.
Lyophilized from a 0.2 µm filtered concentrated solution in 1*PBS, pH7.4, with 3 % Trehalose.
复溶
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Recombinant Human HVEM/TNFRSF14 Protein (rp152533) - SDS-PAGE Recombinant Human HVEM/TNFRSF14 Protein was resolved with SDS-PAGE under reducing (N) and visualized by Coomassie® Blue staining. Showing a band at 70.0 kDa.